tPA should be administered within 4.5 hours of stroke symptom onset for eligible patients with ischemic stroke. The strongest evidence supports treatment within the first 3 hours, but clinical trials have shown it can be safe and effective in selected patients up to 4.5 hours after symptoms begin. The 2026 American Heart Association/American Stroke Association guidelines endorse thrombolytic treatment within this 4.5-hour window for patients with disabling deficits, and even allow for extended treatment up to 9 hours in select cases guided by advanced brain imaging.
How tPA Works
tPA, or tissue plasminogen activator, is a clot-dissolving drug used primarily to treat ischemic stroke, which occurs when a blood clot blocks blood flow to part of the brain. The drug activates a natural protein in the blood called plasminogen, converting it into its active form. That active form then breaks down fibrin, the mesh-like protein that holds blood clots together. As the clot dissolves, blood flow to the brain is restored, limiting the damage caused by oxygen deprivation.
Every minute matters. Brain cells begin dying quickly once blood flow is cut off, which is why tPA’s effectiveness drops sharply with each passing hour.
The Standard 4.5-Hour Window
For nearly two decades, the approved window for tPA was 3 hours from when stroke symptoms first appeared. Randomized clinical trials consistently showed the drug was both safe and effective in that timeframe. More recent trials expanded the window, demonstrating that selected patients could still benefit when treated between 3 and 4.5 hours after onset. The current AHA/ASA guidelines now treat the full 4.5-hour window as the standard timeframe for eligible patients.
Earlier treatment within that window produces better outcomes. A patient treated at 90 minutes will, on average, recover more function than one treated at 4 hours. This is why stroke centers aim for what’s called a “door-to-needle time” of under 60 minutes from hospital arrival to drug infusion.
Extended Window: 4.5 to 9 Hours
For patients who wake up with stroke symptoms or can’t pinpoint exactly when their symptoms started, treatment may still be possible beyond 4.5 hours. The latest guidelines support thrombolysis up to 9 hours from symptom onset for select patients, but only when advanced brain imaging shows there’s still salvageable brain tissue. This imaging looks for a mismatch between the area of brain already damaged and the larger area at risk, suggesting that restoring blood flow could still prevent further injury.
What Must Happen Before tPA Is Given
A brain scan is required before tPA can be administered. The primary purpose is to rule out bleeding in the brain, because tPA dissolves clots. If the stroke is actually caused by a burst blood vessel rather than a blockage, giving a clot-dissolving drug would make the bleeding worse. A non-contrast CT scan is the most common choice because it’s fast, widely available, and highly accurate at detecting hemorrhage. MRI can also be used but takes longer and isn’t always practical for unstable patients.
The key point: the absence of visible damage on a CT scan does not prevent treatment. What matters is confirming there’s no bleeding and no other structural problem that would make tPA dangerous.
Blood pressure must also be controlled before the infusion starts. The target is below 185/110 mmHg. If blood pressure is higher than that, medications are used to bring it down before tPA can be given. After the infusion, blood pressure needs to stay below 180/105 mmHg for the first 24 hours.
Who Cannot Receive tPA
Not every stroke patient is eligible. Several conditions make tPA too risky, and medical teams screen for these quickly in the emergency department.
Absolute contraindications include:
- Bleeding in the brain: Any type of hemorrhage visible on imaging, whether from a bleed within the brain tissue, between brain membranes, or a prior stroke that has started bleeding
- History of brain hemorrhage: Even a past episode rules out treatment
- Active internal bleeding: Ongoing bleeding anywhere in the body
- Blood clotting disorders: Including use of blood thinners that push clotting tests beyond safe thresholds, or a platelet count below 100,000
Relative contraindications require the medical team to weigh risks against benefits:
- Serious head trauma or stroke in the previous 3 months
- Recent major surgery: The definition of “recent” varies, with some trials using a 14-day cutoff and others using 3 months
- Gastrointestinal or urinary tract bleeding within the past 21 days
The guidelines also note that patients with non-disabling deficits, such as isolated numbness without weakness, have not shown clear benefit from tPA. For these milder strokes, antiplatelet therapy with two blood-thinning medications is now the preferred approach.
The Risk of Bleeding Complications
The most serious risk of tPA is symptomatic bleeding in the brain. This is the trade-off that makes timing and patient selection so important. Across large studies, the rate of this complication ranges from about 2% to 7%, depending on the patient population and how the complication is defined. A large U.S. stroke registry tracking over 320,000 patients who received tPA between 2013 and 2021 found an overall rate of 3.3%.
The timing of treatment affects this risk modestly. One major observational study of nearly 24,000 patients found that bleeding occurred in 1.7% of those treated within 3 hours compared to 2.2% of those treated in the 3-to-4.5-hour window.
To put these numbers in perspective: for every 100 stroke patients treated with tPA, roughly 32 benefit from improved recovery while about 3 experience harm from treatment-related bleeding. The math strongly favors treatment for eligible patients, which is why the drug remains a cornerstone of stroke care despite the bleeding risk.
What Happens After tPA Is Given
The hours following tPA infusion involve intensive monitoring. Vital signs and neurological checks happen as often as every 15 minutes, typically requiring a nurse dedicated to one or two patients. This close observation usually continues for at least the first 2 hours. The medical team is watching for any signs that bleeding has occurred, such as sudden worsening of neurological symptoms, severe headache, or a spike in blood pressure.
Patients with more severe strokes generally remain in intensive care for this monitoring period. Those with milder deficits may be candidates for a step-down unit after the initial 2-hour observation window, though practices vary by hospital. Blood pressure monitoring continues for the full 24 hours after treatment, with the goal of keeping it below 180/105 mmHg throughout.